NCT04943666

Brief Summary

Currently in Russia there is no available self-evaluating tools with appropriate diagnostic accuracy for screening of patients with haemorrhoids. Therefore, the primary objective of this study is to evaluate a new patient specific questionnaire (HDQ) with appropriate sensitivity and specificity to use for screening of patients with haemorrhoids in Russia. Once evaluated, the HDQ will be used in clinical practice for wider screening of haemorrhoids in population and for increasing patients' awareness of the disease and prompting them to seek professional advice. Secondary objectives of the study are to describe a prevalence of haemorrhoids among patients in the study and to describe a prevalence of the symptoms of haemorrhoids among patients in the study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
725

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 29, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

July 12, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2023

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

March 5, 2026

Completed
Last Updated

March 5, 2026

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

June 21, 2021

Results QC Date

April 22, 2024

Last Update Submit

March 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensitivity of the HDQ for Screening

    Number of Participants with a false negative screening

    1 month

  • Specificity of the HDQ for Screening

    Number of Participants with a True Positive Screening

    1 month

Secondary Outcomes (2)

  • Prevalence Rate of Haemorrhoids Among Study Population

    1 month

  • Prevalence of the Symptoms of Haemorrhoids Among Patients in the Study

    1 month

Interventions

a new patient specific questionnaire (HDQ) with appropriate sensitivity and specificity to use for screening of patients with haemorrhoids in Russia in clinical practice for wider screening of haemorrhoids in population and for increasing patients' awareness of the disease and prompting them to seek professional advice.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

consecutive patients seeking help from a coloproctologist Limit: 450 characters.

You may qualify if:

  • The patient came to visit a coloproctologist
  • Male or female aged over 18 years
  • Signed informed consent form to participate in the study has been obtained
  • Absence of conditions requiring emergency medical care.

You may not qualify if:

  • Confirmed or suspected malignant tumor
  • Severe somatic disorders (of heart and blood vessels, lungs, kidneys, pancreas, or liver), associated with decompensation of organ functions
  • Mental disorders
  • Presence of contraindications for examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Medical and Surgical Center. N.I. Pirogov

Moscow, Russia

Location

MeSH Terms

Conditions

Hemorrhoids

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Olga linnik
Organization
Servier

Study Officials

  • Yuriy Stoyko, Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2021

First Posted

June 29, 2021

Study Start

July 12, 2021

Primary Completion

November 1, 2022

Study Completion

December 22, 2023

Last Updated

March 5, 2026

Results First Posted

March 5, 2026

Record last verified: 2024-04

Locations